PHAST strengthens market position - partnering Eurofins
PHAST GmbH (headquartered in Homburg/Saar) has signed an agreement this May 08th, 2018 to sell its entire shares to Eurofins BioPharma Services Holding GmbH (headquartered in Planegg/Munich). The transaction, which includes all subsidiaries, still requires the fulfillment of customary closing conditions. Closing date is to be expected within the next 4 to 8 weeks.
Eurofins Scientific (www.eurofins.com) is one of the world’s leading contract research organizations (CROs) for the (bio)pharmaceutical industry with its service portfolio and the network of 28 GMP and GLP laboratories in 16 countries. PHAST, as the market leader in Germany, will add an important element to Eurofins’ network and benefit from it for its own strategic plans in particular from the advanced IT solutions to cater automated processes and manage the digital requirements of the modern facilities both in Homburg and Constance.
Dr. Johannes Krämer, founder and owner of PHAST is looking at the merger mainly from the perspective of insuring the future of PHAST and its employees and states: “PHAST as a service provider for the research focused pharmaceutical industry has continuously grown over the past to meet the challenges of the market. The major increase of outsourcing activities are demanding a consistent expansion of the spectrum of analytical services as well as the laboratory capacity. To keep up with the market’s speed and the trend of consolidation, Eurofins’ support is highly welcomed. This includes both, speed in the field of IT integration and growth of additional lab space at the highest quality. This is key to the position of the brand PHAST in a highly competitive and quality driven environment.”